Table 1.
MGFA class | Number | Age (mean ± SD) | Male/female | IVIg therapy |
---|---|---|---|---|
I | 9 | 39.33 ± 11.24 | 4/5 | 0 |
II | 16 | 37.47 ± 15.21 | 3/13 | 6 |
III | 9 | 43.33 ± 15.46 | 5/4 | 9 |
IV | 5 | 45.60 ± 11.06 | 1/4 | 5 |
Total | 39 | 39.34 ± 14.37 | 13/26 | 20 |
MGFA class | Number | Age (mean ± SD) | Male/female | IVIg therapy |
---|---|---|---|---|
I | 9 | 39.33 ± 11.24 | 4/5 | 0 |
II | 16 | 37.47 ± 15.21 | 3/13 | 6 |
III | 9 | 43.33 ± 15.46 | 5/4 | 9 |
IV | 5 | 45.60 ± 11.06 | 1/4 | 5 |
Total | 39 | 39.34 ± 14.37 | 13/26 | 20 |